Ozempic, Wegovy, and the Economics of Obesity | National Review

Ozempic, Wegovy, and the Economics of Obesity | National Review

Share prices of the companies making popular new weight-loss drugs have soared. Only time will tell if this is merely a display of ‘irrational exuberance.’



Original source

#Ozempic #Wegovy #Economics #Obesity #National #Review

About the Author

Tony Beasley
Tony Beasley writes for the Local News, US and the World Section of ANH.